Treatment of rhinocerebral mucormycosis with intravenous, interstitial, and cerebrospinal fluid administration of amphotericin B: Case report

Neurosurgery

Volumn 42, Issue 3, 1998, Pages 644-649

  Adler, David E ^a   Milhgrat, Thomas H ^a   Miller, John I ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Amphoterecin B; Mucomycosis; Rhinocerebral mucormycosis

Indexed keywords

AMPHOTERICIN B;

ADOLESCENT; ANTIFUNGAL ACTIVITY; APHASIA; ARTICLE; BRAIN ABSCESS; BRAIN INFECTION; CASE REPORT; DYSARTHRIA; FEVER; HEMIPARESIS; HEMIPLEGIA; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCORMYCOSIS; PRIORITY JOURNAL;

ADOLESCENT; AMPHOTERICIN B; BRAIN ABSCESS; BRAIN DISEASES; DEBRIDEMENT; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MUCORMYCOSIS; NOSE DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031933250     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199803000-00037     Document Type: Article

References (36)

1. Anand VK, Alcmar G, Griswold JA Jr: Intracranial complications of mucormycosis: An experimental model and clinical review. Laryngoscope 102:656-662,1992.
2. Armstrong D: Treatment of opportunistic fungal infections. Clin Infect Dis 16:1-9, 1992.
3. Atkins AJ Jr, Bennet JE: Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 13:271-276, 1984.
4. Baker RD: Mucormycosis: A new disease? JAMA 163:805-808, 1957.
5. Baker RD: The phycomycoses. Ann N Y Acad Sci 174:592-605, 1970.
6. Bell WE: Treatment of fungal infections of the central nervous system. Ann Neurol 9:417422, 1981.
7. Blitzer A, Lawson W, Meyers BR, Biller HF: Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 90:635-648, 1980.
8. Chick EW, Evans J, Baker RD: The inhibitory effect of amphotericin B on localized Rhizopits oryzae infection (mucormycosis) utilizing pneumoderma pouch of rat. Antibiot Chemother 8:506-510, 1958.
9. Chick EW, Evans J, Baker RD: Treatment of mucormycosis (Rliizopus oryzac infection) in rabbits with amphotericin B. Antibiot Chemother 8:394-397,1958.
10. Cuadrado LM, Guerrero A, Ascnjo JLG, Martin F, Palau E, Urra DG: Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome. Arch Neurol 45:109-111, 1988.
11. Fisher EW, Toma A, Fisher PH, Cheeseman AD: Rhinocercbral mucormycosis: Use of liposomal amphotericin B. J Laryngol Otol 105: 575-577, 1991.
12. Gregory JE, Golden A, Haymaker W: Mucormycosis of the central nervous system: Report of three cases. Bull Johns Hopkins 73:405419, 1943.
13. Hall WA, Nussbaum ES: Isolated cerebral mucormycosis: Case report and therapeutic considerations. Neurosurgery 36:623,1995 (letter).
14. Hamill R, Oney LA, Crane LR: Successful therapy for rhinocerebral mucormycosis with associated bilateral brain abscesses. Arch Intern Med 141:581-583,1983.
15. Harris JS: Mucormycosis: A report of a case. Pediatrics 16:857-867, 1955.
16. Jones KW, Kaufman L: Development and evaluation of an immunodiffusion test for diagnosis of systemic zygomycosis (mucormycosis): Preliminary report. J Clin Microbiol 7:97-103, 1978.
17. Kucers A, Bennett N McK, Kemp RJ: The use of Antibiotics: A Comprehensive Review with Clinical Empliasis. Philadelphia, J.B. Lippincott, 1987, ed 4, pp 1449-1450.
18. Langmayr JJ, Schwarz A, Buchberger W, Hochleitner W, Twerdy K: Local amphotericin for fungal brain abscess. Lancet 342:123, 1993 (letter).
19. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ: Mucormycosis. Ann Intern Med 93:93-108,1980.
20. Long EL, Weiss DL: Cerebral mucormycosis. Am J Med 26:625-635,1959.
21. Luna JD, Ponssa XS, Rodriguez SD, Luna NC, Juarez CP: Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. Ophthal Surg Lasers 27:706-708, 1996.
22. Masucci EF, Fabara JA, Saini N, Kurtzke JF: Cerebral mucormycosis (phycomycosis) in a heroin addict. Arch Neurol 39:304-306,1982.
23. Meyer RD: Current role of therapy with amphotericin B. Clin Infect Dis 14[Suppl 1]: S154-S160, 1992.
24. Meyers BR, Wormser G, Hirschman Z, Blitzer A: Rhinocerebral mucormycosis: Premortem diagnosis and therapy. Arch Intern Med 139:557560,1979.
25. Nussbaum ES, Hall WA: Rhinocerebral mucormycosis: Changing patterns of disease. Surg Neurol 41:152-156,1994.
26. Ostrow RD, Hudgins PA: Magnetic resonance imaging of intracranial fungal infections. Top Magn Reson Imaging 6:22-31,1994.
27. Parfrey NA: Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 3 cases. Medicine 65:113-123,1986.
28. Pierce PF Jr, Solomon SL, Kaufman L, Garagusi VF, Parker RH, Ajell L: Zygomycetes brain abscesses in narcotic addicts with serological diagnosis. JAMA 248:281-282,1982.
29. Pillsbury HC, Fischer MD: Rhinocerebral mucormycosis. Arch Otolaryngol 103:600-604,1977.
30. Rangel-Guerra R, Martinez HR, Saenz C: Mucormycosis: Report of 11 cases. Arch Neurol 42:578-581, 1985.
31. Sandier R, Tallman CB, Keamy DG, Irving WR: Successfully treated rhinocerebral phycomycosis in well controlled diabetes. New Engl J Med 285:1180-1182,1971.
32. Smith HW, Kirschner JA: Cerebral mucormycosis: A report of three cases. Arch Otolaryngol 68:715-726,1958.
33. Stave GM, Heimberger R, Kerkering RM: Zygomycosis of the basal ganglia in intravenous drug users. Am J Med 86:115-117,1989.
34. Sugar AM: Mucormycosis. Clin Infect Dis 14[Suppl 11:5126-5129, 1992.
35. Woods KF, Hanna BJ: Brain stem mucormycosis in a narcotic addict with eventual recovery. Am J Med 80:126-128,1986.
36. Young RF, Gade G, Grinnell V: Surgical treatment for fungal infections in the central nervous system. J Neurosurg 63:371-381,1985.